Skip to main content
# Title Department Research Member Research Year
81 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
82 Detection of Epstein-Barr virus Latent Membrane Protein-1 in Pediatric Lymphoma: A Report from South Egypt Cancer Institute Department of Pediatric Oncology Dr. Shimaa Hassan Shabaan Hassan 2022
83 Pharmacokinetics and Pharmacodynamics of Dexmedetomidine Administered as an Adjunct to Bupivacaine for Transversus Abdominis Plane Block in Patients Undergoing Lower Abdominal Cancer Surgery Department of Anesthesia, Intensive care and Pain management Dr. Neveen Abdelazeem Abdelraheem 2022
84 Spastic paraplegia 20 and serine/threonine protein kinase 31 expression for the detection of colorectal cancer" Department of Cancer Biology Dr. Noha gaber sayed 2022
85 Pharmacokinetics and Pharmacodynamics of Dexmedetomidine Administered as an Adjunct to Bupivacaine for Transversus Abdominis Plane Block in Patients Undergoing Lower Abdominal Cancer Surgery Department of Anesthesia, Intensive care and Pain management Dr. Fatma Adel Abd Diab. 2022
86 Malnutrition Assessment in Pediatric Acute Lymphoblastic Leukemia in Upper Egypt and Its Effect on Induction Response Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2022
87 The Advantage of Drug-Eluting Trans-Arterial Chemo-embolization Over The Conventional Technique in The Management of Hepatocellular Carcinoma (Bi-Institutional Study) Department of Radiology Dr. Omar Mustafa Mahmoud Mohamed 2022
88 T-lymphocytes expression of Toll-like receptors 2 and 4 in acute myeloid leukemia patients with invasive fungal infections Department of Clinical Pathology Dr. Samar Muhammad mansour 2022
89 Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer Department of Clinical Pathology Dr. Dalia Osama Mohamed Ahmed 2022
90 Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2022